Haemonetics Corp (HAE)

R&D Expense Growth

12.14%

Quarterly · Period ending:

HAE logo

HAE R&D Expense Growth

Latest reported12.14%
HAE Quarterly R&D Growth (QoQ) (0.00% → 12.14%)
High-resolution chart · PNG

HAE r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Haemonetics Corp R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
12.1418%
1.1129%
-1.625%
-10.6881%
1.8923%
0.8213%
11.9528%
-2.1455%
-40.9208%
84.3724%
4.7375%
0.1344%
-47.6143%
90.275%
16.4556%
-0.055%
-49.5511%
115.3034%
-7.5187%
-14.55%
-31.8726%
148.5402%
10.9123%
-12.7355%
-54.8736%
145.3429%
-5.6858%
-0.8682%
-14.4049%
-2.573%
4.6021%
-8.7497%
-15.1619%
-10.783%
65.2307%
-8.2021%
-56.9266%
124.7814%
1.5115%
-27.1138%
-48.1292%
101.508%
-5.2887%
2.0493%
-34.2758%
61.8435%
-2.697%
-28.8909%
11.1737%
-2.6251%
-4.9311%
33.3393%
-37.0917%
68.2849%
-2.2074%
15.0707%
9.2672%
-6.7266%
-10.8019%
20.223%
-2.0146%
9.8799%
0.528%
0.4293%
18.8832%
3.111%
-0.2162%
-4.4562%
-2.6013%
19.1438%
11.9417%
-10.729%
0.9326%
4.7206%
-17.8088%
7.1861%
-4.022%
12.6637%
-5.1479%
12.855%
3.691%
-44.7427%
50.6128%
13.3911%
8.5832%
-22.4939%
54.8084%
4.9087%
-1.1702%
0.7367%
-11.8996%
-7.5045%
3.4576%
4.2521%
-9.3346%
3.4622%
190.8572%
-135.8907%
203.6488%
4.68%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.